查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1831926

2025-2033 年阿片类药物市场报告（按产品类型、应用、配销通路和地区）

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球阿片类药物市场规模达225亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到288亿美元，2025-2033年期间的复合年增长率（CAGR）为2.65%。慢性疼痛发生率上升、老龄人口增加、癌症诊断率上升、医疗服务可及性改善、持续的研发投入、消费者意识的提升以及有利的政府法规是推动市场发展的主要因素。

阿片类药物市场趋势：

慢性疼痛盛行率不断上升

全球慢性疼痛发生率的上升是阿片类药物产业成长的主要驱动力。 2021年，超过20.9%的美国成年人（5,160万人）患有慢性疼痛，而6.9%（1,710万人）报告患有高强度慢性疼痛（即严重限制日常活动的疼痛）。数百万人患有慢性疼痛，这种疼痛通常由关节炎、背痛或神经性疾病等疾病引起，促进了有效疼痛管理疗法的使用。根据美国疾病管制与预防中心（CDC）的数据，2019-2021年，约有5,320万美国人（21.2%）被医生诊断出患有关节炎。因此，阿片类药物因其治疗剧烈疼痛的有效性而被医疗保健从业者开立处方。

老年人口不断增加

老年人口的不断增长推动了阿片类药物行业的发展。 2022 年，全球 65 岁及以上人口为 7.71 亿，约占全球人口的 10%。 2022 年，印度 60 岁及以上人口为 1.49 亿，约占总人口的 10.5%。此外，预计 2023 年欧盟人口将达到 4.488 亿，其中超过五分之一（21.3%）为 65 岁及以上。老年人更容易因与年龄相关的疾病（如退化性关节病变和癌症）而忍受慢性疼痛。这增加了对疼痛治疗选择的需求。据估计，在美国 65 岁及以上的成年人中，47% 被诊断出患有关节炎。此外，骨关节炎是第二常见风湿病，也是最常见的关节疾病，在印度的盛行率为22%至39%。近45%的65岁以上女性出现骨关节炎症状，而70%的65岁以上女性有放射学证据。

全球癌症发生率上升

癌症诊断率的上升，尤其是在新兴国家，正在刺激鸦片类药物的需求。国际癌症研究机构 (IARC) 估计，2022 年将新增 2,000 万例癌症病例，死亡人数达 970 万人。预计癌症确诊后五年存活的人数将达 5,350 万人。此外，大约每五人中就有一人在一生中罹患癌症，其中每九名男性中就有一人死于癌症，每十二名女性中就有一人死于癌症。癌症患者常会经历剧烈疼痛，而鸦片类药物是癌症疼痛治疗的重要组成部分。随着全球癌症发生率的上升，对有效疼痛管理的需求也在增长，从而推动了阿片类药物产业的扩张。

阿片类药物市场细分：

按产品类型细分：

  • 可待因
  • 芬太尼
  • 美沙酮
  • 羟可酮
  • 吗啡
  • 氢可酮

羟可酮占据大部分市场份额

根据鸦片类药物市场统计数据，羟考酮凭藉其强效的止痛特性，已成为一种主流产品，尤其适用于治疗术后和癌症相关疼痛等重度疼痛。当其他疼痛管理方案效果不佳时，医师通常会开立羟考酮处方。此外，製药业已投入大量资金开发羟考酮缓释製剂，以更短的给药间隔提供更持久的疼痛缓解。此外，羟考酮的多功能性使其具有多种给药途径，包括口服片剂、胶囊和静脉注射剂型，可满足不同患者的需求，从而推动其应用。

按应用分类：

  • 疼痛管理
  • 咳嗽治疗
  • 腹泻治疗
  • 其他的

疼痛管理占产业最大份额

从阿片类药物市场趋势来看，疼痛管理占据了最大的市场。阿片类药物在医疗保健领域的重要角色以及人们对有效缓解疼痛重要性的日益认识，推动了其在疼痛管理领域的应用。疼痛是一种普遍而复杂的医学问题，影响着全球数百万人，而阿片类药物被认为是治疗中度至重度疼痛的关键成分，尤其是在急性和慢性疼痛、术后恢復以及癌症相关疼痛方面。由于老年人口的迅速增长和癌症诊断率的上升，疼痛相关疾病的普遍存在，从而对有效的疼痛缓解方法产生了持续的需求，这正在提升阿片类药物的市场份额。

按配销通路细分：

  • 医院药房
  • 零售药局
  • 药局
  • 网上商店
  • 其他的

根据阿片类药物市场概况，医院药房是重要的配销通路，因为这些场所是患者首次接触阿片类药物处方的地方，尤其是在术后或用于急性疼痛治疗​​时。它们确保阿片类药物的分销和使用得到严格控制，在医生监督下将阿片类药物的处方与用药直接联繫起来。

根据鸦片类药物市场分析，零售药局是患者取得慢性疼痛治疗​​的鸦片类药物处方最便捷的管道。它们满足了患者在医院外持续的用药需求，促进了医疗保健提供者处方的连续性。零售药局提供广泛的供应和便利性，并且在某些地区还提供咨询服务以确保安全使用，从而推动了阿片类药物市场的收入成长。

根据阿片类药物市场报告，药局提供更广泛的购物体验，尤其註重健康。它们为患者提供便捷的选择，让他们能够同时取得药物和其他保健产品。药局在鸦片类药物产业中的作用凸显了在取得必需药物的可及性与限制处方药取得以防止滥用的责任之间的平衡。

线上药局是阿片类药物市场中一个不断成长的细分市场，为患者提供便利且价格更低的药品。此外，数位医疗技术的快速发展和消费者行为的转变也推动了人们向线上购物的转变。同时，线上药局也为医疗资源匮乏地区或农村地区提供了更多获得疼痛管理解决方案的机会。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据鸦片类药物最大市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是阿片类药物最大的区域市场。

从阿片类药物市场前景来看，北美地区占据了主导市场份额，这得益于多种因素，包括背痛和骨关节炎等慢性疼痛疾病的高发病率、人口老龄化以及阿片类药物在疼痛管理中的广泛使用。此外，医疗基础设施的改善和人们对疼痛管理方案认识的提高，也导致了阿片类药物处方率的提高，从而对阿片类药物市场需求产生了积极影响。此外，专业的成瘾治疗中心和药房已成为分销管道，满足了这些药物的需求。此外，受更严格的指导方针和处方监控项目的影响，不断变化的法规和处方实践也正在影响阿片类药物市场的成长。

本报告回答的关键问题：

  • 全球阿片类药物市场迄今表现如何，未来几年将如何表现？
  • 全球阿片类药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球鸦片类药物市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的鸦片类药物市场？
  • 根据产品类型，市场是如何分類的？
  • 阿片类药物市场上最具吸引力的产品类型是什么？
  • 根据应用，市场是如何分類的？
  • 阿片类药物市场中最具吸引力的应用是什么？
  • 根据配销通路，市场是如何分類的？
  • 阿片类药物市场中最具吸引力的配销通路是什么？
  • 市场的竞争结构是怎么样的？
  • 全球阿片类药物市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 全球阿片类药物市场迄今表现如何？未来几年将如何表现？
  • 全球阿片类药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球鸦片类药物市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的鸦片类药物市场？
  • 根据产品类型，市场是如何分類的？
  • 阿片类药物市场上最具吸引力的产品类型是什么？
  • 根据应用，市场是如何分類的？
  • 阿片类药物市场中最具吸引力的应用是什么？
  • 根据配销通路，市场是如何分類的？
  • 阿片类药物市场中最具吸引力的配销通路是什么？
  • 市场的竞争结构是怎么样的？
  • 全球阿片类药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球鸦片类药物市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 可待因
  • 芬太尼
  • 美沙酮
  • 羟可酮
  • 吗啡
  • 氢可酮

第七章：市场区隔：依应用

  • 疼痛管理
  • 咳嗽治疗
  • 腹泻治疗
  • 其他的

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 药局
  • 网上商店
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma LP
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A4559

The global opioids market size reached USD 22.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 28.8 Billion by 2033, exhibiting a growth rate (CAGR) of 2.65% during 2025-2033. The rising incidence of chronic pain conditions, increasing elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids Market Trends:

Increasing prevalence of chronic pain

The increasing incidence of chronic pain throughout the world is a primary driver of opioid industry growth. In 2021, over 20.9% of U.S. adults (51.6 million) suffered chronic pain, while 6.9% (17.1 million) reported high-impact chronic pain (i.e., pain that significantly limits daily activities). Millions of people suffer from chronic pain, which is commonly caused by ailments, such as arthritis, back difficulties, or neuropathic disorders, boosting the use of effective pain management treatments. In 2019-2021, around 53.2 million US individuals (21.2%) had arthritis diagnosed by a doctor, according to the Center for Disease Control and Prevention (CDC). As a result, opioids are prescribed by healthcare practitioners because of their effectiveness in treating severe pain.

Growing geriatric population

The opioids industry is driven by the growing geriatric population. In 2022, there were 771 million persons aged 65 and over, accounting for about 10% of the global population. In 2022, 14.9 crore people in India were recorded to be 60 years or older, accounting for approximately 10.5% of the total population. In addition, the population of the European Union (EU) was predicted to be 448.8 million in 2023, with more than one-fifth (21.3%) of it aged 65 and more. Geriatric individuals are more likely to endure chronic pain due to age-related disorders, such as degenerative joint disease and cancer. This has raised the need for pain treatment choices. It is estimated that among adults aged 65 and older, 47% are diagnosed with arthritis in the USA. Also, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Nearly, 45% of women over the age of 65 years have symptoms while radiological evidence is found in 70% of those over 65 years.

Rising cancer rates across the globe

The increasing rate of cancer diagnoses, particularly in emerging nations, is fueling the demand for opioids. The International Agency for Research on Cancer (IARC) estimated that 20 million new cancer cases and 9.7 million deaths occurred in 2022. The expected number of persons who survived 5 years after a cancer diagnosis was 53.5 million. Furthermore, around one in every five persons develops cancer during their lifetime, with one in every nine men and one in every twelve women dying from the condition. Cancer patients frequently experience significant pain, and opioids are a key component of cancer pain therapy. As cancer rates increase internationally, so does the demand for effective pain management, driving the opioid industry expansion.

Opioids Market Segmentation:

Breakup by Product Type:

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Oxycodone accounts for the majority of the market share

According to the opioids market statistics, oxycodone has emerged as a dominant product type owing to its potent pain-relieving properties, which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is propelling its adoption.

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Pain management holds the largest share of the industry

Based on the opioid market trends, pain management accounted for the largest market share. Opioid's fundamental role in the healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain refers to a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the burgeoning geriatric population and the rising incidence of cancer diagnoses, thereby creating a sustained demand for effective pain relief methods, is bolstering the opioids market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

According to the opioids market overview, hospital pharmacies represent a critical distribution channel as these settings are the first encounters of opioid prescriptions for patients, especially after surgeries or for acute pain management. They ensure controlled distribution and use, providing a direct link between the prescription and administration of opioids under medical supervision.

As per the opioids market analysis, retail pharmacies serve as the most accessible point for patients to fill opioid prescriptions for chronic pain management. They cater to the ongoing needs of patients outside the hospital setting, facilitating the continuity of care prescribed by healthcare providers. Retail pharmacies offer widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.

According to the opioids market report, drug stores offer a broader shopping experience with a particular focus on health. They provide a convenient option for patients to access their medications along with other healthcare products. The role of drug stores in the opioid industry underscores the balance between accessibility to necessary medications and the responsibility to limit access to prescription drugs to prevent abuse.

Online pharmacies represent a growing segment in the opioid market, offering patients convenience and lower prices for their medications. Moreover, rapid advancements in digital health technologies and changing consumer behaviors are favoring the shift toward online shopping. Along with this, online pharmacies increase access to pain management solutions in underserved or rural areas.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest opioids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for opioids.

As per the opioids market outlook, The North American region dominated the market share due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the opioid market demand. Moreover, specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs, are influencing the opioid market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc.
  • According to recent research that analyzes the opioid market's recent developments, it has been found that leading pharmaceutical companies are investing heavily in research and development (R&D) to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid market companies are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the opioids market's recent price and opportunities.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players